0002-7772 : Ebglyss 250 mg/2ml Subcutaneous Injection, Solution


NDC: 0002-7772
Labeler: Eli Lilly and Company
Product Type: Human Prescription Drug
Drug Name:  Ebglyss
Dosage Form: Subcutaneous Injection, Solution
Application #: BLA761306
Rev. Date: 


NDC Package Codes:

  • 0002-7772-11: 1 SYRINGE IN 1 CARTON (0002‑7772‑11) / 1 ML IN 1 SYRINGE (0002‑7772‑01)
  • 0002-7772-62: 2 SYRINGE IN 1 CARTON (0002‑7772‑62) / 1 ML IN 1 SYRINGE

Active Ingredients:

  • Lebrikizumab

Dosage Strength:

  • 250 mg/2mL

Pharmaceutical Classes:

  • Interleukin-13 Antagonist [EPC]
  • Interleukin-13 Antagonists [MoA]

Related Products:

Based on records with the same trade name.
  • 0002-7797 Ebglyss 250 mg/2ml Subcutaneous Injection, Solution by Eli Lilly and Company

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0002-7772 QR Code

< Prev: 0002-7752Next: 0002-7797 >

Related Discussions:

Ebglyss and Skin Peeling: A Normal Reaction?
I took my initial loading dose of Ebglyss 6 days ago and I'm noticing skin peeling where my eczema is. Is this norma...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.